Encephalomyosynangiosis

The key biological change is development of collateral vessels from extracranial tissue toward the cerebral cortex. Because the temporalis muscle remains vascularized when placed against the brain surface, its vessels can extend into ischemic neural tissue. This creates an alternative route for cerebral blood flow, supporting regions that receive inadequate perfusion through their existing circulation.

Encephalomyosynangiosis works gradually because new collateral circulation develops after the vascularized muscle is positioned, rather than producing its full circulatory effect during surgery. This delay explains why postoperative observation remains important. Neurological benefit and reduced risk of ischemic stroke depend on the later formation of vessels capable of improving blood supply to affected brain tissue.

The temporalis muscle is not used simply as a physical covering. Its vascularized portion serves as the extracranial source of vessels that can grow toward the cerebral cortex. Direct contact with the brain’s surface places this blood-supplying tissue next to ischemic neural regions, establishing the anatomical relationship needed for indirect revascularization.

Inadequate cerebral perfusion is the central physiological problem addressed by this approach. When the brain receives insufficient blood flow, ischemic tissue is at risk of neurological dysfunction and stroke. By promoting collateral circulation, the operation aims to improve supply to affected cortical regions and support neurological function rather than treating the problem as a purely structural abnormality.

During the operation, a vascularized portion of temporalis muscle is positioned directly on the cerebral surface. The essential procedural goal is to place extracranial, blood-supplying tissue against the cortex so vessel growth can occur afterward. The intervention is therefore an indirect bypass: its intended circulatory effect develops progressively after surgery rather than being fully present immediately.

It is used primarily for patients with moyamoya disease, a setting associated with inadequate cerebral perfusion. The technique may also be considered for other conditions involving insufficient blood flow to the brain. Its clinical purpose is to encourage collateral supply, reduce the risk of ischemic stroke, and support neurological function as revascularization develops.

Postoperative monitoring is necessary because the desired collateral circulation forms over time. Clinicians must follow the patient while the brain transitions from inadequate perfusion toward improved blood supply, assessing neurological status and the evolving therapeutic effect. This follow-up is especially important because the operation’s benefit is delayed rather than immediate.